[TEVA] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 109.27%
YoY- 42.86%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 4,162,000 3,832,000 4,457,000 3,850,000 3,878,000 3,661,000 3,884,000 4.72%
PBT -246,000 -467,000 473,000 75,000 -914,000 -258,000 -1,100,000 -63.19%
Tax 630,000 -52,000 41,000 -12,000 -16,000 -19,000 154,000 156.00%
NP -845,000 -139,000 429,000 80,000 -863,000 -205,000 -1,221,000 -21.77%
Tax Rate - - -8.67% 16.00% - - - -
Total Cost 5,007,000 3,971,000 4,028,000 3,770,000 4,741,000 3,866,000 5,105,000 -1.28%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -20.30 -3.63 9.63 2.08 -22.25 -5.60 -31.44 -25.31%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.75 -0.12 0.41 0.07 -0.77 -0.18 -1.10 -22.55%
EPS Diluted -0.75 -0.12 0.41 0.07 -0.77 -0.18 -1.10 -22.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.